Alexandre Lopez

Alexandre Lopez has a diverse work experience. Alexandre began their career as a research assistant at McGill University in 2013. In 2014, they completed an internship at the University of Cambridge. From 2015 to 2019, they worked as a PhD student at INSERM U935, focusing on chronotherapy of cancers and liver function optimization. In 2019, they joined Institut Georges Lopez (IGL) as the Director of Research and Development and later became the Chief Executive Officer in 2021. In 2023, they will assume the position of Chief Executive Officer at CAIR LGL.

Alexandre Lopez completed their education from Université Paris-Saclay as they earned a Doctor of Philosophy (PhD) degree in Biologie cellulaire et anatomie from 2015 to 2019. Prior to that, they pursued a Master's degree in Génétique, Biollogie Cellulaire et Pathologies from Université Claude Bernard Lyon 1 from 2012 to 2014. Alexandre's educational journey started with a Bachelor's degree in Sciences, Technologies et Santé from the same university, which they completed from 2010 to 2012.